| Identification | Back Directory | [Name]
leucyl-arginyl-prolyl-glycinamide | [CAS]
38482-71-2 | [Synonyms]
leucyl-arginyl-prolyl-glycinamide Glycinamide, L-leucyl-L-arginyl-L-prolyl- | [Molecular Formula]
C19H36N8O4 | [MOL File]
38482-71-2.mol | [Molecular Weight]
440.54 |
| Hazard Information | Back Directory | [Uses]
LH-RH (7-10) is a tetrapeptide, one of major degradation products of luteinising-hormone releasing hormone (LHRH) via pituitary and hypothalamus. LH-RH (7-10) produced in macrophages, type I-like and type II pneumocytes[3]. | [in vivo]
LH-RH (7-10) (i.v.) increases esterase activity in plasma kinin system in rats[1].
LH-RH (7-10) (ntracarotid infusion i.v.; single dose) stimulates a significant increase in plasma LH concentration in the jugular vein[2].
| Animal Model: | New Zealand White Rabbit[2] | | Dosage: |
100, 500 and 2500 ng dissolved in 0-9% (w/v) NaCl solution and diluted | | Administration: | Ntracarotid infusion; infused with a constant volume of 7-5 mL per 30 min | | Result: | Caused LH release in the female rabbit during various reproductive conditions. |
| [References]
[1] Mandzhikyan, et al. Effect of luteinizing hormone releasing hormone fragments on the rat plasma kinin system. Russian. 1979; 69(2):115-118. [2] Carlson JC, et al. The effect of LH-RH administration on LH release in the female rabbit. J Reprod Fertil. 1979 May;56(1):175-80. DOI:10.1530/jrf.0.0560175 [3] Yang X, et al. Enzymatic degradation of luteinizing hormone releasing hormone (LHRH)/[D-Ala6]-LHRH in lung pneumocytes. Pharm Res. 1998 Sep;15(9):1480-4. DOI:10.1023/a:1011926310666 [4] Talwar GP, et al. Bioeffective monoclonal antibody against the decapeptide gonadotropin-releasing hormone: reacting determinant and action on ovulation and estrus suppression. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1228-31. DOI:10.1073/pnas.82.4.1228 |
|
|